在鹿特丹举办的第16届年度国际溶瘤病毒疗法会议（IOVC）：面向溶瘤病毒疗法的梦想家和实干家。

The 16th Annual International Oncolytic Virotherapy Conference (IOVC) in Rotterdam: For the dreamers and doers of oncolytic virotherapy.

作者信息

Olagnier David, Alain Tommy

机构信息

Aarhus University, Department of Biomedicine, Aarhus C, 8000, Denmark.

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, K1H 8L1, Canada, Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.

出版信息

Virologie (Montrouge). 2025 Apr 5;29(3):0. doi: 10.1684/vir.2025.1077.

DOI:10.1684/vir.2025.1077

PMID:40186367

Abstract

From October 27-30 2024, the 16th International Oncolytic Virotherapy Conference (IOVC) was held in Rotterdam, the Netherlands, a city that mirrors the spirit of resilience, conviction, and innovation of researchers in the field of oncolytic viruses. Rotterdam, renowned for its post-war rebuilding with cutting-edge architecture designed for a bright future in mind, provided a fitting reflection that oncolytic virotherapy is at a turning point in its evolution. Hosted at the International Congress Center De Doelen, the event gathered clinicians, scientists, and biotech leaders to showcase the most up-to-date clinical applications, novel viral platforms, targeted mechanisms, and immune-modulating strategies that will push the boundaries of cancer immunotherapy into the next era. We present here an overview of this engaging meeting and offer our own perspectives on where to dream and continue to build.

摘要

2024年10月27日至30日，第16届国际溶瘤病毒疗法会议（IOVC）在荷兰鹿特丹举行。鹿特丹这座城市体现了溶瘤病毒领域研究人员的坚韧、信念和创新精神。鹿特丹以其战后重建而闻名，其前沿建筑着眼于光明的未来，这恰如其分地反映出溶瘤病毒疗法正处于发展的转折点。该活动在国际会议中心德多伦举行，汇聚了临床医生、科学家和生物技术领域的领导者，展示了最新的临床应用、新型病毒平台、靶向机制以及免疫调节策略，这些将推动癌症免疫疗法进入下一个时代。在此，我们概述这次引人入胜的会议，并就未来的梦想和持续发展方向提出我们自己的观点。